VMP 41765111000001109

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Lenalidomide 5mg capsules
BNF code 0802040Y0AAAAAA
Virtual Therapeutic Moiety Lenalidomide
Date identifier became valid 9 May 2023
Previous product identifier 422330004
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units capsule
Unit dose unit of measure capsule
Virtual Product Ingredient
Ingredient Lenalidomide
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 5.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route capsule.oral
Dose Form
Formulation Oral capsule
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Lenalidomide 5mg capsules (Accord-UK Ltd)
Lenalidomide 5mg capsules (Advanz Pharma)
Lenalidomide 5mg capsules (Amarox Ltd)
Lenalidomide 5mg capsules (Sandoz Ltd)
Lenalidomide 5mg capsules (Sun Pharmaceutical Industries Europe B.V.)
Lenalidomide 5mg capsules (Teva UK Ltd)
Lenalidomide 5mg capsules (Thornton & Ross Ltd)
Lenalidomide 5mg capsules (Torrent Pharma (UK) Ltd)
Lenalidomide 5mg capsules (Viatris UK Healthcare Ltd)
Lenalidomide 5mg capsules (Zentiva Pharma UK Ltd)
Revlimid 5mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
Virtual Medicinal Product Packs
Lenalidomide 5mg capsules 21 capsule
Lenalidomide 5mg capsules 7 capsule

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback